Wednesday, July 8, 2026

pharma · Rheumatoid Arthritis · Calcium

Universal Integrated

Universal Integrated clinical programs — 22 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

HILLSIDE, NJ, CN HQ
2006 Founded
304 Employees
NMPA registrant Type
Company details
Status
Public
HQ
HILLSIDE, NJ, CN
Founded
2006
Employees
304
Programs
89
Drugs
105
Patents
42
Intelligence · Clinical Programs

Universal Integrated projects

22 ClinicalTrials.gov programs sponsored by Universal Integrated.

Universal Integrated has 22 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. BaidI Quzhi granule

    Universal Integrated

    Acne Vulgaris

    phase 3 small molecule active

    1 trial
  2. Donepezil

    Universal Integrated

    Osteoarthritis

    phase 3 small molecule active

    1 trial
  3. Ear pills

    Universal Integrated

    Intradialytic Hypotension

    phase 3 small molecule active

    1 trial
  4. G-Pen

    Universal Integrated

    Insulin Hypoglycemia

    phase 3 small molecule completed

    1 trial
  5. Galantamine

    Universal Integrated

    Acute Ischemic Stroke AIS

    phase 3 small molecule active

    1 trial
  6. Ginkgo Diterpene Lactone Meglumine Injection

    Universal Integrated

    Ischemic Stroke

    phase 3 small molecule active

    1 trial
  7. Ginkgo diterpene lactone meglumine injection

    Universal Integrated

    Ischemic Stroke, Acute

    phase 3 small molecule active

    1 trial
  8. Infliximab + methotrexate (IFX + MTX)

    Universal Integrated

    Arthritis, Psoriatic

    phase 3 small molecule completed

    1 trial
  9. Infliximab Increased Frequency

    Universal Integrated

    Rheumatoid Arthritis

    phase 3 small molecule terminated

    1 trial
  10. Intensive medical therapy

    Universal Integrated

    Myocardial Ischemia

    phase 3 other completed

    1 trial
  11. Juanbi pill

    Universal Integrated

    Juanbi Pill

    phase 3 small molecule active

    1 trial
  12. NiuBangZi pill or NiuBangZi pill placebo

    Universal Integrated

    Niu Bang Zi Pill

    phase 3 small molecule active

    1 trial
  13. PEG-Interferon a-2b + Ribavirin

    Universal Integrated

    Chronic Hepatitis C Infection in HIV-Infected Persons

    phase 3 small molecule completed

    1 trial
  14. Peg interferon alpha-2b

    Universal Integrated

    Hepatitis C

    phase 3 small molecule terminated

    1 trial
  15. PegIntron (peginterferon alfa-2b)

    Universal Integrated

    Hepatitis C, Chronic

    phase 3 mab terminated

    1 trial
  16. Qing'E pills

    Universal Integrated

    Menopause

    phase 3 small molecule completed

    1 trial
  17. Sevoflurane

    Universal Integrated

    Anesthesia

    phase 3 small molecule completed

    1 trial
  18. Surgery and HIPEC with Lobaplatin

    Universal Integrated

    Colorectal Neoplasms

    phase 3 other active

    1 trial
  19. Tirofiban

    Universal Integrated

    Acute Ischemic Stroke

    phase 3 small molecule completed

    1 trial
  20. UIC-BKL-2013

    Universal Integrated

    Bowel Preparation Before Colonoscopy

    phase 3 small molecule completed

    1 trial
  21. UIC-STP-2017

    Universal Integrated

    Bowel Preparation

    phase 3 small molecule completed

    1 trial
  22. peginterferon alfa-2b (SCH 54031)

    Universal Integrated

    Hepatitis C, Chronic

    phase 3 mab completed

    1 trial

Frequently asked questions

How many clinical projects does Universal Integrated have?

22 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.